Maxygen assists with library design and overall project development. Maxygen is a leader in the application of synthetic biology to directed evolution for protein engineering.

Maxygen, Inc. (Maxygen) is a biotechnology company focused on the development of its MAXY-G34 product candidate. MAXY-G34 is a pegylated, granulocyte colony stimulating factor (G-CSF)...

Последние твиты от Maxygen (@MaxygenLLC). MAXYGEN is a fee-for-service CRO offering custom programs to solve Client's protein engineering and optimization needs by molecular breeding directed...

Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies.

Maxygen Inc. (Nasdaq: MAXY) is a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies.

Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies.

Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies.

Maxygen Inc. (Nasdaq: MAXY) is a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies.

Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies. The company was headquartered in Redwood City, CA. It dissolved in 2013.

Maxygen, Moscow, Russia. 9 likes. Мобильная ДНК-диагностика. Maxygen. Biotechnology company in Moscow, Russia.

Maxygen | 200 followers on LinkedIn. Utilizing the well-established molecular breeding directed evolution technology, Maxygen creates high-quality recombinant libraries based on functional...

Maxygen Inc was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification techn.

Maxygen Inc. Maxygen, Inc. operates as a biopharmaceutical company. The Company develops protein pharmaceuticals for the treatment of disease and serious medical conditions.

Maxygen is a biopharmaceutical company focused on developing improved versions of protein MAXY-G34 is currently in Phase II clinical trials. Also in Maxygen's pipeline are a new Factor VIIa...

A high-level overview of Maxygen, Inc. (MAXY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Maxygen has 6 employees at their 1 location. See insights on Maxygen including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies.

Articles Figures Tables About. Maxygen. Willem Stemmer at Maxygen invented a method of directed evolution that uses both mutation and recombination.

library(maxygen) macument(pkg_dir). You can use the macument() command instead of devtools::document() to create the Rd documentation from Markdown-Roxygen. macument...

Maxygen Inc. , DNA karıştırma ve diğer protein modifikasyon teknolojilerini kullanarak protein ilaçlarının geliştirilmiş versiyonlarını geliştirmeye odaklanmış bir biyofarmasötik şirketti . Şirketin merkezi Redwood City, CA adresindeydi. 2013'te çözüldü.

Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies.